相关实验视频
Updated: Jun 1, 2025

04:28
Lung Tumor Cell Recruitment Assay
Published on: February 26, 2019
5.3K
JAM2的异常表达抑制了肺腺癌的入侵和迁移
Jun Chen1,2, Yuan Cui1,2, Zhimeng Chen1,2
1Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Cancer reports (Hoboken, N.J.)
|January 22, 2025
概括
交界粘附分子2 (JAM2) 在肺腺癌 (LUAD) 中被下调. 抑制JAM2抑制LUAD细胞迁移和入侵,表明其作为预后和治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肺腺癌 (LUAD) 是肺癌最常见的组织学亚型.
- 结点粘附分子2 (JAM2) 涉及细胞与细胞相互作用和瘤进展.
- 在LUAD中JAM2的特定作用和临床意义在很大程度上仍未被探索.
研究的目的:
- 研究JAM2在LUAD中的表达模式和功能角色.
- 评估JAM2作为一个潜在的预后生物标志物来评估LUAD患者的结果.
- 评估JAM2作为LUAD早期诊断和治疗的分子点的实用性.
主要方法:
- 在37个LUAD组织对上进行免疫组织化学 (IHC).
- 基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 路径分析.
- 在体外实验中评估JAM2过度表达对LUAD细胞迁移和入侵的影响.
主要成果:
- 发现JAM2表达在LUAD组织中被下调,可能是通过甲基化.
- JAM2 作为一个独立的预后标志物,用于 LUAD 患者的结果.
- 过度表达JAM2显著抑制了LUAD细胞迁移和入侵,与炎症透和免疫治疗反应相关.
结论:
- JAM2下调是LUAD发展的一个关键特征.
- JAM2 显示出作为 LUAD 的预后生物标志物和治疗点的巨大潜力.
- 进一步研究JAM2在LUAD病原和治疗中的作用是有必要的.
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Cell Migration
4.7K
Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.
4.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

